CORE--OUTPATIENT FACILITY
CORE--OUTPATIENT FACILITY
批准号:
5206716
负责人:
DEBORAH C MARCELLUS
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
门诊设施的目标是:
英文摘要
The objectives of the Outpatient Facility are:
1. To provide a common resource for Project 1-5
The facilities of the Outpatient Clinic (OPD) are essential for the
acquisition of clinical data required to accomplish the aims of the
various projects. It is in the OPD that assessments of sustained
engraftment, tumors response, acute and chronic GVHD, manifestations of
immunodeficiency, post-engraftment infections and other complications of
bone marrow transplant are made. As well as clinical evaluations, the
OPD provides a means for procuring blood and tissue specimens for
multiple investigators.
2. To provide a systematic approach to the evaluation and management of
late complications. The incidence and severity of multiple organ
toxicities after BMT is under active investigation. A systematic
approach to the follow-up of all patients will allow us to determine the
contribution of multiple factors (such as age, preparative regimen, type
of transplant, post-transplant immunosuppression) to the risk for the
toxicities observed. In addition, it is anticipated that management
approaches to the complications identified will be developed and
investigated.
3. To prospectively evaluate chronic GVHD
A systematic evaluation of patients with chronic GVHD will be carried
out. A staging system for this condition will be developed as outlined
in Project 2. Patients and clinical specimens for Phase II and Phase
III therapeutic studies descried in Project 2 will be obtained in the
OPD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BRYOSTATIN 1 THERAPY FOLLOWED BY VAD FOR MULTIPLE MYELOMA
-
批准号:6297464
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:DEBORAH C MARCELLUS
-
依托单位:
BRYOSTATIN 1 THERAPY FOLLOWED BY VAD FOR MULTIPLE MYELOMA
-
批准号:6264075
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:DEBORAH C MARCELLUS
-
依托单位:
海外基金